The post From our CEO appeared first on MS Australia. Source: www.msaustralia.org.au
Category: Multiple Sclerosis Research
Thanks to MS, I can relate to my skeleton Halloween costume
I’m not sure exactly when it happened, but at some point, I stopped putting on a costume and going trick-or-treating for Halloween. Years passed, and with the arrival of my […] The post Thanks to MS, I can relate to my skeleton Halloween costume appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
ENHANCE trial testing simplified Briumvi dosing now fully enrolled
Enrollment is complete for the randomized part of ENHANCE, a large clinical trial testing a new dosing schedule for Briumvi (ublituximab-xiiy) in adults with relapsing forms of multiple sclerosis (MS), […] The post ENHANCE trial testing simplified Briumvi dosing now fully enrolled appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
High-carb diet may raise MS risk, especially for women: Study
Eating more carbohydrates significantly increases the risk of developing multiple sclerosis (MS), particularly among women and people younger than 60, according to a study based on data from the U.K. […] The post High-carb diet may raise MS risk, especially for women: Study appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
EBV as a cause in Children
Tweet EBV as the cause of MS…but that means everyone with MS has to be infected with EBV…one negative and “the” cause has to change to “a” cause. In most studies with children, the rate of EBV positivitiy seldom reached 100% but not in this study. 100% in MS, 59% in controls, 70% with headache…..so…
MTS-004 eases pseudobulbar affect in people with MS, other disorders
Metis Biotech‘s experimental oral therapy MTS-004 was safe and eased symptoms of pseudobulbar affect (PBA), a neurological condition marked by bouts of sudden, involuntary, and inappropriate laughter or crying, in […] The post MTS-004 eases pseudobulbar affect in people with MS, other disorders appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Why I’ve been living a sheltered life since my MS diagnosis
As I sit down at my desk to write this, tears are streaming down my face. My mind, soul, body, and heart are beyond wounded from living with relapsing-remitting multiple […] The post Why I’ve been living a sheltered life since my MS diagnosis appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Obexelimab stops new MS brain lesions in clinical trial, data show
Obexelimab, a therapy Zenas Biopharma is developing for a range of autoimmune diseases, almost completely prevented the formation of new inflammatory lesions in adults with relapsing forms of multiple sclerosis […] The post Obexelimab stops new MS brain lesions in clinical trial, data show appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Connecting to Your Creativity
Self-expression is a tool that can unleash your creativity in a unique way. It is not just a way to beat your internal stress; it is a self-defense mechanism that is powerful and can reveal a lot about our inner … Continue reading → Source: blog.mymsaa.org
Gateway Drugs I understand…but Do Gateway Animal Studies translate
Tweet As a card carrying EAEer I understand the view that studies in animal studies give the basis for benefit in controlling MS. Indeed this is the basis for many animal studies. Aliyu M, Saboor-Yaraghi AA, Sahraian MA, Noorbakhsh F.. The Experimental Autoimmune Encephalomyelitis (EAE) Model: A Gateway to Successful Translation of Multiple Sclerosis Therapies. The study talks…